Table 3.

Predictive power of new plaque formation rate for incident CV events as adjusted for other risk factors in bivariate Cox regression analyses

Adjusted for	Hazard Ratio (95% CI), P (1 plaque/yr increase)
Age	1.29 (1.12–1.50), <0.001
Sex	1.26 (1.08–1.47), 0.003
BMI	1.33 (1.14–1.55), <0.001
Smoking	1.23 (1.05–1.43), 0.01
Diabetes	1.31 (1.14–1.53), <0.001
Previous CV events	1.28 (1.10–1.48), 0.001
Antihypertensive treatment	1.31 (1.13–1.53), <0.001
CRP	1.41 (1.14–1.76), 0.002
Homocysteine	1.31 (1.13–1.51), <0.001
Cholesterol	1.32 (1.14–1.52), <0.001
Hemoglobin	1.31 (1.14–1.51), <0.001
Albumin	1.32 (1.14–1.54), <0.001
Calcium*phosphate	1.34 (1.15–1.56), <0.001
Systolic pressure	1.31 (1.13–1.53), <0.001
Diastolic pressure	1.37 (1.18–1.60), <0.001
LVMI	1.26 (1.08–1.47), 0.003
Ejection fraction	1.30 (1.11–1.53), 0.001
Baseline no. of plaques	1.24 (1.03–1.48), 0.02
Baseline IMT	1.27 (1.09–1.48), 0.002
Baseline CCAD	1.34 (1.15–1.57), <0.001
Baseline CSA	1.29 (1.10–1.51), 0.001
Baseline CCAwlr	1.29 (1.11–1.51), 0.001
Changes in IMT	1.31 (1.13–1.51), <0.001
Changes in CCAD	1.31 (1.14–1.52), <0.001
Changes in CSA	1.31 (1.14–1.51), <0.001
Changes in CCAwlr	1.31 (1.13–1.52), <0.001

CCAD, common carotid artery diameter; CCAwlr, common carotid artery wall to lumen ratio; CSA, cross-sectional area.